• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
OTC Pharmaceuticals in Switzerland - Product Image

OTC Pharmaceuticals in Switzerland

  • Published: August 2013
  • Region: Switzerland
  • 38 pages
  • MarketLine

Introduction

OTC Pharmaceuticals in Switzerland industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Switzerland otc pharmaceuticals market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Highlights

- The OTC pharmaceuticals market consists of the retail sale of traditional medicines, cough and cold preparations (tablets, mixtures, lozenges, topical remedies, inhalers), vitamins and minerals (multi-vitamins, single minerals, single vitamins, tonics, cod liver oil), indigestion preparations (tablets, powders, mixtures), analgesics (Paracetamol, Ibuprofen, Aspirinand other analgesics), and medicated skin products (anti-bacteria’s, acne treatments, anti-fungal, disinfectants and other), topical OTC medicines (anesthetic products, anti-itch READ MORE >

Executive Summary
Market value
Market value forecast
Category segmentation
Market share
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Category segmentation
Market share
Market distribution
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
Bayer AG
GlaxoSmithKline Plc
Johnson & Johnson
Novartis AG
Macroeconomic Indicators
Country Data
Appendix
Methodology
Industry associations
Related MarketLine research

LIST OF TABLES
Table 1: Switzerland OTC pharmaceuticals market value: $ million, 2008–12
Table 2: Switzerland OTC pharmaceuticals market category segmentation: $ million, 2012
Table 3: Switzerland OTC pharmaceuticals market share: % share, by value, 2012
Table 4: Switzerland OTC pharmaceuticals market distribution: % share, by value, 2012
Table 5: Switzerland OTC pharmaceuticals market value forecast: $ million, 2012–17
Table 6: Bayer AG: key facts
Table 7: Bayer AG: key financials ($)
Table 8: Bayer AG: key financials (€)
Table 9: Bayer AG: key financial ratios
Table 10: GlaxoSmithKline Plc: key facts
Table 11: GlaxoSmithKline Plc: key financials ($)
Table 12: GlaxoSmithKline Plc: key financials (£)
Table 13: GlaxoSmithKline Plc: key financial ratios
Table 14: Johnson & Johnson: key facts
Table 15: Johnson & Johnson: key financials ($)
Table 16: Johnson & Johnson: key financial ratios
Table 17: Novartis AG: key facts
Table 18: Novartis AG: key financials ($)
Table 19: Novartis AG: key financial ratios
Table 20: Switzerland size of population (million), 2008–12
Table 21: Switzerland gdp (constant 2000 prices, $ billion), 2008–12
Table 22: Switzerland gdp (current prices, $ billion), 2008–12
Table 23: Switzerland inflation, 2008–12
Table 24: Switzerland consumer price index (absolute), 2008–12
Table 25: Switzerland exchange rate, 2008–12

LIST OF FIGURES
Figure 1: Switzerland OTC pharmaceuticals market value: $ million, 2008–12
Figure 2: Switzerland OTC pharmaceuticals market category segmentation: % share, by value, 2012
Figure 3: Switzerland OTC pharmaceuticals market share: % share, by value, 2012
Figure 4: Switzerland OTC pharmaceuticals market distribution: % share, by value, 2012
Figure 5: Switzerland OTC pharmaceuticals market value forecast: $ million, 2012–17
Figure 6: Forces driving competition in the OTC pharmaceuticals market in Switzerland, 2012
Figure 7: Drivers of buyer power in the OTC pharmaceuticals market in Switzerland, 2012
Figure 8: Drivers of supplier power in the OTC pharmaceuticals market in Switzerland, 2012
Figure 9: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Switzerland, 2012
Figure 10: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Switzerland, 2012
Figure 11: Drivers of degree of rivalry in the OTC pharmaceuticals market in Switzerland, 2012
Figure 12: Bayer AG: revenues & profitability
Figure 13: Bayer AG: assets & liabilities
Figure 14: GlaxoSmithKline Plc: revenues & profitability
Figure 15: GlaxoSmithKline Plc: assets & liabilities
Figure 16: Johnson & Johnson: revenues & profitability
Figure 17: Johnson & Johnson: assets & liabilities
Figure 18: Novartis AG: revenues & profitability
Figure 19: Novartis AG: assets & liabilities

Bayer AG, GlaxoSmithKline Plc, Johnson & Johnson and Novartis AG

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos